Abdominal Neoplasms - 350 Studies Found
| Active, not recruiting |
: BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer : Ovarian Cancer, Peritoneal Neoplasms : 2013-02-08 |
| Completed |
: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer :
|
| Recruiting |
: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer :
|
| Terminated |
: Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer :
|
| Terminated |
: Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer :
|
| Active, not recruiting |
: VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer :
|
| Active, not recruiting |
: CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer :
|
| Completed |
: A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer :
|
| Active, not recruiting |
: Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer :
|
| Active, not recruiting |
: A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer :
|